Detection of Epstein-Barr virus DNA in sera from transplant recipients with lymphoproliferative disorders

J Clin Microbiol. 1999 Apr;37(4):1113-6. doi: 10.1128/JCM.37.4.1113-1116.1999.

Abstract

Early diagnosis of Epstein-Barr Virus (EBV)-associated posttransplant lymphoproliferative disease (PTLD) is important because many patients respond to reduction in immunosuppression, especially if PTLD is detected at an early stage. Previous studies have found elevated EBV DNA levels in blood from patients with PTLD, but these assays required isolation of cellular blood fractions and quantitation. We evaluated the presence of cell-free EBV DNA in serum from solid-organ transplant recipients as a marker for PTLD. Five of 6 transplant recipients with histopathologically documented PTLD had EBV DNA detected in serum at the time of diagnosis (sensitivity = 83%), compared with 0 of 16 matched transplant recipients without PTLD (specificity = 100%) (P < 0.001 [Fisher's exact test]). Furthermore, EBV DNA was detected in serum 8 and 52 months prior to the diagnosis of PTLD in two of three patients for whom stored sera were analyzed. Detection of EBV DNA in serum appears to be a useful marker for the early detection of PTLD in solid-organ transplant recipients. Further studies to define the role of such assays in evaluating solid-organ transplant patients at risk for PTLD are warranted.

MeSH terms

  • Adult
  • Base Sequence
  • Biomarkers / blood
  • DNA Primers / genetics
  • DNA, Viral / blood*
  • DNA, Viral / genetics
  • Female
  • Herpesvirus 4, Human / genetics
  • Herpesvirus 4, Human / isolation & purification*
  • Humans
  • Kidney Transplantation / adverse effects
  • Liver Transplantation / adverse effects
  • Lymphoproliferative Disorders / diagnosis
  • Lymphoproliferative Disorders / etiology*
  • Lymphoproliferative Disorders / virology*
  • Male
  • Middle Aged
  • Organ Transplantation / adverse effects*
  • Pancreas Transplantation / adverse effects
  • Polymerase Chain Reaction
  • Retrospective Studies
  • Risk Factors
  • Time Factors

Substances

  • Biomarkers
  • DNA Primers
  • DNA, Viral